[go: up one dir, main page]

MX2018000166A - Metodos para una mejor administración de agentes activos a tumores. - Google Patents

Metodos para una mejor administración de agentes activos a tumores.

Info

Publication number
MX2018000166A
MX2018000166A MX2018000166A MX2018000166A MX2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A
Authority
MX
Mexico
Prior art keywords
methods
tumors
active agents
better delivery
agents
Prior art date
Application number
MX2018000166A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MX2018000166A publication Critical patent/MX2018000166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a la administración de agentes a través de la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para la administración dirigida de agentes a una o más áreas de la epidermis y, de esta manera, a uno o más tumores de cáncer.
MX2018000166A 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores. MX2018000166A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196578P 2015-07-24 2015-07-24
US201562196570P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
MX2018000166A true MX2018000166A (es) 2018-03-26

Family

ID=57885141

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000166A MX2018000166A (es) 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores.
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Country Status (15)

Country Link
US (3) US10806913B2 (es)
EP (2) EP3325080B1 (es)
JP (1) JP7082041B2 (es)
KR (1) KR20180035209A (es)
CN (2) CN118902979A (es)
AU (3) AU2016297823B2 (es)
BR (1) BR112018001292A2 (es)
CA (1) CA2991455C (es)
DK (1) DK3325080T3 (es)
ES (1) ES2891523T3 (es)
HU (1) HUE056410T2 (es)
MX (2) MX2018000166A (es)
PL (1) PL3325080T3 (es)
RU (1) RU2719943C2 (es)
WO (1) WO2017019526A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3325080B1 (en) * 2015-07-24 2021-09-01 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
EP3922238A1 (en) * 2015-07-24 2021-12-15 Sorrento Therapeutics, Inc. Methods for lymphatic delivery of active agents
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
AU2018269704B2 (en) 2017-05-17 2024-02-08 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2019012382A1 (en) 2017-07-10 2019-01-17 Basf Se MIXTURES COMPRISING A UREASE INHIBITOR (UI) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
JP2021525576A (ja) * 2018-05-31 2021-09-27 ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． リンパ系を標的化した薬物送達方法
EP3856322A1 (en) 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for in-situ reaction of a skin
EP3856321A1 (en) * 2018-09-24 2021-08-04 L'oreal Device comprising microneedles for skin-coloring
MX2022006786A (es) * 2019-12-05 2022-07-19 Sorrento Therapeutics Inc Método de tratamiento de cáncer mediante la administración de un agente terapéutico anti-pd-1 o anti-pd-l1 mediante un dispositivo de administración linfática.
WO2022159736A1 (en) 2021-01-22 2022-07-28 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN117916264A (zh) 2021-06-09 2024-04-19 索伦托药业有限公司 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法
AU2022329961A1 (en) 2021-08-18 2024-03-28 Sofusa Holdings Llc Therapeutic agents targeting the lymphatic system
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
ES2210168T3 (es) 2000-06-01 2004-07-01 Watson Pharmaceuticals, Inc. Dispositivo transdermico de lasofoxileno.
BRPI0212496B8 (pt) * 2001-09-12 2021-06-22 Becton Dickinson And Company Bd dispositivo tipo caneta baseado em uma micro agulha para distribuição de medicamentos e método de utilização do mesmo
CA2529048A1 (en) * 2003-06-13 2005-02-24 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
WO2005023328A2 (en) 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
EP1893130A4 (en) * 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
RU2585138C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Медицинские устройства для доставки кирнк
BR112012027672A2 (pt) 2010-04-28 2023-12-05 Kimberly Clark Co Dispositivo médico compreendendo um conjunto de microagulhas que se estendem para fora a partir de um suporte e método para formar um dispositivo médico
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
RU2585159C2 (ru) 2010-04-28 2016-05-27 Кимберли-Кларк Ворлдвайд, Инк. Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
EP3608394A1 (en) * 2011-10-17 2020-02-12 Massachusetts Institute Of Technology Intracellular delivery
WO2013061208A1 (en) 2011-10-27 2013-05-02 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
CN110025881A (zh) * 2012-09-13 2019-07-19 亚夫拉罕·阿米尔 用于皮肤改善的递送装置和方法
SG10202011046RA (en) * 2012-09-21 2020-12-30 Intensity Therapeutics Inc Method of treating cancer
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
WO2014132239A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Drug delivery device
JP6522523B2 (ja) 2013-02-28 2019-05-29 ソレント・セラピューティクス・インコーポレイテッド 経皮的薬物送達装置
KR20160004394A (ko) 2013-05-23 2016-01-12 킴벌리-클라크 월드와이드, 인크. 개선된 개방 채널 단면 구조를 갖는 미세침
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
EP3325080B1 (en) * 2015-07-24 2021-09-01 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
EP3922238A1 (en) * 2015-07-24 2021-12-15 Sorrento Therapeutics, Inc. Methods for lymphatic delivery of active agents

Also Published As

Publication number Publication date
AU2016297823B2 (en) 2020-10-22
CN118902979A (zh) 2024-11-08
RU2719943C2 (ru) 2020-04-23
RU2018104102A3 (es) 2019-11-06
CN107921248A (zh) 2018-04-17
CA2991455C (en) 2023-10-10
US10806913B2 (en) 2020-10-20
DK3325080T3 (da) 2021-10-04
EP3925599A1 (en) 2021-12-22
RU2018104102A (ru) 2019-08-27
JP7082041B2 (ja) 2022-06-07
JP2018521755A (ja) 2018-08-09
US20180193624A1 (en) 2018-07-12
KR20180035209A (ko) 2018-04-05
WO2017019526A2 (en) 2017-02-02
US20240238570A1 (en) 2024-07-18
CA2991455A1 (en) 2017-02-02
HUE056410T2 (hu) 2022-02-28
BR112018001292A2 (pt) 2018-09-11
AU2016297823A1 (en) 2018-02-15
MX2022014277A (es) 2022-12-07
EP3325080B1 (en) 2021-09-01
EP3325080A4 (en) 2019-04-17
US20210052871A1 (en) 2021-02-25
PL3325080T3 (pl) 2022-01-24
ES2891523T3 (es) 2022-01-28
AU2021200146B2 (en) 2022-08-25
EP3325080A2 (en) 2018-05-30
AU2022275397A1 (en) 2023-01-05
AU2021200146A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
MX2018000166A (es) Metodos para una mejor administración de agentes activos a tumores.
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
MX2021013830A (es) Inhibidores de ezh2 para tratar linfomas.
MX373187B (es) Terapia de combinación para tratar cáncer.
ECSP15026557A (es) Compuestos y sus métodos de empleo
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
SV2017005489A (es) Terapias de combinación para el tratamiento de cánceres
MX376329B (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
MX2019008085A (es) Antagonistas de activina-actrii y usos para tratar transtornos oseos y otros.
MY188139A (en) Sodium channel modulators for the treatment of pain
DOP2015000189A (es) Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico
MX2017017079A (es) Sistema de administracion dirigida de principio activo celular.
DOP2017000035A (es) Inhibidores de la proteina quinasa c y metodos de su uso
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
MX385762B (es) Métodos para el control transcripcional objetivo en regiones del super mejorador.
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
EA201591924A1 (ru) Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
EA201591925A1 (ru) Терапевтические композиции и их применение
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
MX2016009284A (es) Construcciones dirigidas a receptor y sus usos.
MX383944B (es) Composiciones para el cuidado personal.
BR112018002530A2 (pt) combinações e usos e tratamentos destas
SG11201610947UA (en) Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment